OxyContin maker Purdue Pharma and its owners agreed to pay up to $7.4 billion in a new settlement, officials in Mass. and ...

The deal replaces a previous, $6 billion agreement that was rejected last July by the Supreme Court because it would have ...

The Sackler family and Purdue Pharma agreed to pay $7.4 billion to settle lawsuits over the toll of the powerful prescription ...

This story incorporates reporting fromBoston.com, Philadelphia Inquirer, The Boston Globe, pharmaphorum, Hartford Courant, BioSpace and Yahoo.

The proposed settlement calls on the Sacklers to pay $1.5 billion in the first three years, followed by $500 million after ...

The Sackler family agreed to give up ownership of the company that manufactures the powerful opioid. A previous deal was ...

The Office of the Attorney General came to a $7.4 billion settlement with the Sackler family and their company, Purdue Pharma ...

The settlement is the largest deal to date with the people primarily who played an “instrumental role” in driving the opioid ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...

A bipartisan coalition of states has reached a $7.4 billion settlement in principle with members of the Sackler family and their former company Purdue Pharma over their role in the opioid crisis.

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the ...

Pennsylvania may receive up to $212 million over 15 years as part of a multi-state lawsuit settlement with Purdue Pharma and ...